Fort Worth, Texas-based ZS Pharma has recently been named a finalist for the prestigious National Business Incubation Association’s 2013 Outstanding Incubator Client award in the technology category for its innovative drug for patients suffering with kidney and liver disease. The award will be announced in Boston on April 9th as part of the NBIA’s 27th International Conference on Business Incubation.
According to the Fort Worth Star-Telegram, ZS Pharma’s consideration for the award is directly connected to the company being an Acceleration client of TECH Fort Worth, a business incubator. Speaking on the honor of being named a finalist in the award contention, Darlene Ryan, TECH Fort Worth executive director commented that:
“This is huge recognition, for ZS Pharma and for TECH Fort Worth, as the competition for this award is on an international playing field of all clients of technology incubators. The criteria include not only the success of the client, but also the role that the incubator played in helping it get there.”